SEC Form 4 · Updated Daily
ONC
— BeOne Medicines Ltd. OwnershipInsider and institutional ownership derived from SEC Form 4 filings. Click any owner to see their holdings across every company they’ve filed on, and how their position has changed over time.
Current Reporting Owners
| Owner | Role | Shares Owned | As Of | Last Activity |
|---|---|---|---|---|
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | 10%+ Owner | 125,045,741 | 2024-12-02 | S |
| HHLR ADVISORS, LTD. | 10%+ Owner | 125,045,741 | 2024-12-02 | S |
| CITIC PE Associates, L.P. | 10%+ Owner | 19,601,138 | 2016-02-08 | C |
| CITIC PE Funds Ltd | 10%+ Owner | 19,601,138 | 2016-02-08 | C |
| CB Biotech Investment Ltd | 10%+ Owner | 19,601,138 | 2016-02-08 | C |
| CPEChina Fund, L.P. | 10%+ Owner | 19,601,138 | 2016-02-08 | C |
| AMGEN INC | 10%+ Owner | 18,943,802 | 2021-09-10 | P |
| Merck Sharp & Dohme Research GmbH | 10%+ Owner | 18,518,519 | 2016-02-08 | C |
| Merck Sharp & Dohme Corp. | 10%+ Owner | 18,518,519 | 2016-02-08 | C |
| Merck & Co., Inc. | 10%+ Owner | 18,518,519 | 2016-02-08 | C |
| BAKER FELIX | 10%+ Owner · Director | 8,099,179 | 2026-09-14 | M |
| 667, L.P. | 10%+ Owner · Director | 8,099,179 | 2026-09-14 | M |
| BAKER JULIAN | 10%+ Owner · Director | 8,099,179 | 2026-09-14 | M |
| BAKER BROS. ADVISORS LP | 10%+ Owner · Director | 8,099,179 | 2026-09-14 | M |
| Baker Bros. Advisors (GP) LLC | 10%+ Owner · Director | 8,099,179 | 2026-09-14 | M |
| Baker Brothers Life Sciences LP | 10%+ Owner · Director | 8,099,179 | 2026-09-14 | M |
| Glazer Donald W. | Director | 2,718,464 | 2024-06-05 | A |
| OYLER JOHN | Director · Officer | 240,743 | 2026-08-10 | S |
| Yang Jianxin | Officer | 200,000 | 2016-02-02 | — |
| Yuan RuiRong | Officer | 130,000 | 2016-02-08 | P |
| HOOPER ANTHONY C | Director | 83,720 | 2026-06-11 | A |
| Dugan Margaret | Director | 73,164 | 2026-06-11 | A |
| Riva Alessandro | Director | 73,164 | 2026-06-11 | A |
| Malley Thomas | Director | 46,696 | 2023-06-15 | A |
| BRANDICOURT OLIVIER | Director | 46,306 | 2026-06-11 | A |
| Sharp Shalini | Director | 38,116 | 2026-06-11 | A |
| Wang Xiaodong | Director | 31,027 | 2026-10-13 | M |
| Sawyers Charles Lazelle | Director | 18,984 | 2026-06-11 | A |
| Mooney Elizabeth Fisher | Director | 18,980 | 2026-06-11 | A |
| Peterson Amy C. | Officer | 10,141 | 2018-12-18 | M |
| Li Ji | Officer | 10,000 | 2018-02-28 | M |
| su Jingshyh S | Director | 7,800 | 2021-06-16 | A |
| Chen Timothy Yung-Cheng | Director | 7,800 | 2021-06-16 | A |
| 14159, L.P. | 10%+ Owner · Director | 7,102 | 2017-10-13 | J |
| Huang Jane | Officer | 1,500 | 2021-12-14 | M |
| Lee Chan Henry | Officer | 0 | 2026-09-30 | S |
| Ball Titus B. | Officer | 0 | 2026-09-01 | S |
| Wang Lai | Officer | 0 | 2026-06-23 | S |
| Rosenberg Aaron | Officer | 0 | 2026-08-03 | S |
| Wu Xiaobin | Officer | 0 | 2026-08-25 | S |
| Yi Qingqing | Director | 0 | 2026-06-01 | S |
| Wang Julia Aijun | Officer | 0 | 2024-07-01 | S |
| Sanders Corazon (Corsee) D. | Director | 0 | 2026-05-22 | S |
| Liang Howard | Officer | 0 | 2021-06-28 | S |
Recent Filings
| Date | Owner | Activity | Shares | Price | Owned After |
|---|---|---|---|---|---|
| 2026-10-13 | Wang Xiaodong | Option exercise (derivative) | 403,351 | $0.00 | 403,364 |
| 2026-10-13 | Wang Xiaodong | Open-market sale | 1,260 | $353.24 | 0 |
| 2026-10-13 | Wang Xiaodong | Open-market sale | 6,558 | $352.57 | 1,260 |
| 2026-10-13 | Wang Xiaodong | Open-market sale | 5,681 | $351.40 | 7,818 |
| 2026-10-13 | Wang Xiaodong | Open-market sale | 10,361 | $350.47 | 13,499 |
| 2026-10-13 | Wang Xiaodong | Open-market sale | 7,167 | $349.56 | 23,860 |
| 2026-10-13 | Wang Xiaodong | Option exercise | 31,027 | $36.90 | 31,027 |
| 2026-09-30 | Lee Chan Henry | Open-market sale | 1,115 | $375.00 | 0 |
| 2026-09-28 | Wang Xiaodong | Option exercise (derivative) | 403,364 | $0.00 | 806,715 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 738 | $367.23 | 0 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 14,525 | $366.58 | 738 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 2,047 | $365.85 | 15,263 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 3,419 | $364.07 | 17,310 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 3,499 | $363.10 | 20,729 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 4,239 | $362.17 | 24,228 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 2,241 | $361.05 | 28,467 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 40 | $359.16 | 30,708 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 120 | $358.71 | 30,748 |
| 2026-09-28 | Wang Xiaodong | Open-market sale | 160 | $356.97 | 30,868 |
| 2026-09-28 | Wang Xiaodong | Option exercise | 31,028 | $36.90 | 31,028 |
| 2026-09-14 | BAKER JULIAN | Option exercise (derivative) | 30,768 | $0.00 | 0 |
| 2026-09-14 | BAKER JULIAN | Option exercise | 30,768 | $36.83 | 8,099,179 |
| 2026-09-14 | BAKER JULIAN | Option exercise | 30,768 | $36.83 | 761,410 |
| 2026-09-14 | BAKER FELIX | Option exercise (derivative) | 30,768 | $0.00 | 0 |
| 2026-09-14 | BAKER FELIX | Option exercise | 30,768 | $36.83 | 8,099,179 |
| 2026-09-14 | BAKER FELIX | Option exercise | 30,768 | $36.83 | 761,410 |
| 2026-09-14 | Baker Brothers Life Sciences LP | Option exercise (derivative) | 30,768 | $0.00 | 0 |
| 2026-09-14 | Baker Brothers Life Sciences LP | Option exercise | 30,768 | $36.83 | 8,099,179 |
| 2026-09-14 | Baker Brothers Life Sciences LP | Option exercise | 30,768 | $36.83 | 761,410 |
| 2026-09-14 | Baker Bros. Advisors (GP) LLC | Option exercise (derivative) | 30,768 | $0.00 | 0 |
| 2026-09-14 | Baker Bros. Advisors (GP) LLC | Option exercise | 30,768 | $36.83 | 8,099,179 |
| 2026-09-14 | Baker Bros. Advisors (GP) LLC | Option exercise | 30,768 | $36.83 | 761,410 |
| 2026-09-14 | 667, L.P. | Option exercise (derivative) | 30,768 | $0.00 | 0 |
| 2026-09-14 | 667, L.P. | Option exercise | 30,768 | $36.83 | 8,099,179 |
| 2026-09-14 | 667, L.P. | Option exercise | 30,768 | $36.83 | 761,410 |
| 2026-09-14 | BAKER BROS. ADVISORS LP | Option exercise (derivative) | 30,768 | $0.00 | 0 |
| 2026-09-14 | BAKER BROS. ADVISORS LP | Option exercise | 30,768 | $36.83 | 8,099,179 |
| 2026-09-14 | BAKER BROS. ADVISORS LP | Option exercise | 30,768 | $36.83 | 761,410 |
| 2026-09-08 | Wang Xiaodong | Option exercise (derivative) | 403,351 | $0.00 | 1,210,079 |
| 2026-09-08 | Wang Xiaodong | Open-market sale | 6,569 | $350.27 | 6,278 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.